Apocynin ameliorates diabetic retinopathy in rats: Involvement of TLR4/NF-κB signaling pathway

Area of Science:

• Ophthalmology
• Endocrinology
• Pharmacology

Background:

• Diabetic retinopathy (DR) is a leading cause of vision loss in diabetic patients.
• The Toll-like receptor 4 (TLR4)/nuclear factor-kappa B (NF-κB) pathway is implicated in DR pathogenesis.
• Apocynin, a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor, reduces superoxide radicals and has shown potential in inhibiting the TLR4/NF-κB pathway.

Purpose of the Study:

• To investigate the therapeutic efficacy of apocynin in a rat model of diabetic retinopathy.
• To determine if apocynin's protective effects are mediated through the inhibition of the TLR4/NF-κB signaling pathway.

Main Methods:

• Diabetic rat model induced by streptozotocin.
• 12-week treatment with apocynin (16 mg/kg/day) or vehicle.
• Assessment of gene expression (Western blot, qRT-PCR), retinal morphology (Hematoxylin-Eosin staining), oxidative stress, and apoptosis.

Main Results:

• Apocynin treatment significantly improved biochemical markers and retinal morphology in diabetic rats.
• Apocynin administration reduced retinal cell apoptosis, oxidative stress, and inflammation.
• Inhibition of the TLR4/NF-κB signaling pathway was observed in apocynin-treated diabetic rats.

Conclusions:

• Apocynin demonstrates significant ameliorative effects on diabetic retinopathy in a rat model.
• The therapeutic benefits of apocynin are associated with the inhibition of the TLR4/NF-κB pathway.
• Apocynin holds considerable therapeutic potential for the treatment of diabetic retinopathy.